b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1177995/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Peptide inhibitors of dengue virus and West Nile virus infectivity</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1177995/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Virology Journal" /><meta name="citation_title" content="Peptide inhibitors of dengue virus and West Nile virus infectivity" /><meta name="citation_authors" content="Yancey M Hrobowski, Robert F Garry, Scott F Michael" /><meta name="citation_date" content="2005" /><meta name="citation_volume" content="2" /><meta name="citation_doi" content="10.1186/1743-422X-2-49" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1177995/?report=abstract" /><meta name="citation_pmid" content="15927084" /><meta name="DC.Title" content="Peptide inhibitors of dengue virus and West Nile virus infectivity" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Yancey M Hrobowski" /><meta name="DC.Contributor" content="Robert F Garry" /><meta name="DC.Contributor" content="Scott F Michael" /><meta name="DC.Date" content="2005" /><meta name="DC.Identifier" content="10.1186/1743-422X-2-49" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Peptide inhibitors of dengue virus and West Nile virus infectivity" /><meta property="og:type" content="article" /><meta property="og:description" content="Viral fusion proteins mediate cell entry by undergoing a series of conformational changes that result in virion-target cell membrane fusion. Class I viral fusion proteins, such as those encoded by influenza virus and human immunodeficiency virus (HIV), ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1177995/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1177995/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1177995/pdf/12985_2005_Article_64.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B663BE999B4710000000007490749.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1177995</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Virology Journal</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Virol J</span>. 2005; 2: 49. </span></div><div><span class="fm-vol-iss-date">Published online 2005 Jun 1. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1743-422X-2-49" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1743-422X-2-49</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1177995</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/15927084">15927084</a></div></div></div></div><h1 class="content-title">Peptide inhibitors of dengue virus and West Nile virus infectivity</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Hrobowski%20YM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15927084" class="affpopup" co-rid="_co_idm140190340407520" co-class="co-affbox">Yancey M Hrobowski</a>,<sup>1</sup> <a href="/pubmed/?term=Garry%20RF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15927084" class="affpopup" co-rid="_co_idm140190418664480" co-class="co-affbox">Robert F Garry</a>,<sup>1,</sup><sup>2</sup> and  <a href="/pubmed/?term=Michael%20SF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15927084" class="affpopup" co-rid="_co_idm140190342058112" co-class="co-affbox">Scott F Michael</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140190340407520"><h3 class="no_margin">Yancey M Hrobowski</h3><p><sup>1</sup>Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112 USA </p><div>Find articles by <a href="/pubmed/?term=Hrobowski%20YM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15927084">Yancey M Hrobowski</a></div></div><div id="_co_idm140190418664480"><h3 class="no_margin">Robert F Garry</h3><p><sup>1</sup>Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112 USA </p><p><sup>2</sup>Graduate Program in Cellular and Molecular Biology, Tulane University, New Orleans, LA 70112 USA </p><div>Find articles by <a href="/pubmed/?term=Garry%20RF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15927084">Robert F Garry</a></div></div><div id="_co_idm140190342058112"><h3 class="no_margin">Scott F Michael</h3><p><sup>3</sup>Biotechnology Program, Florida Gulf Coast University, Fort Myers, FL 33965 USA </p><div>Find articles by <a href="/pubmed/?term=Michael%20SF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15927084">Scott F Michael</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140190337551152_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140190337551152_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140190337551152_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140190337551152_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112 USA </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Graduate Program in Cellular and Molecular Biology, Tulane University, New Orleans, LA 70112 USA </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Biotechnology Program, Florida Gulf Coast University, Fort Myers, FL 33965 USA </div><div><span class="fm-affl">Yancey M Hrobowski, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.enalut@swoborhy" class="oemail">ude.enalut@swoborhy</a></span>.</div><div><a href="#idm140190337551152aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140190337551152_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2005 May 20; Accepted 2005 Jun 1.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140190337551152_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Hrobowski et al; licensee BioMed Central Ltd. 2005</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1177995/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first">Viral fusion proteins mediate cell entry by undergoing a series of conformational changes that result in virion-target cell membrane fusion. Class I viral fusion proteins, such as those encoded by influenza virus and human immunodeficiency virus (HIV), contain two prominent alpha helices. Peptides that mimic portions of these alpha helices inhibit structural rearrangements of the fusion proteins and prevent viral infection. The envelope glycoprotein (E) of flaviviruses, such as West Nile virus (WNV) and dengue virus (DENV), are class II viral fusion proteins comprised predominantly of beta sheets. We used a physio-chemical algorithm, the Wimley-White interfacial hydrophobicity scale (WWIHS) [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>] in combination with known structural data to identify potential peptide inhibitors of WNV and DENV infectivity that target the viral E protein. Viral inhibition assays confirm that several of these peptides specifically interfere with target virus entry with 50% inhibitory concentration (IC50) in the 10 &#x003bc;M range. Inhibitory peptides similar in sequence to domains with a significant WWIHS scores, including domain II (IIb), and the stem domain, were detected. DN59, a peptide corresponding to the stem domain of DENV, inhibited infection by DENV (&#x0003e;99% inhibition of plaque formation at a concentrations of &#x0003c;25 &#x003bc;M) and cross-inhibition of WNV fusion/infectivity (&#x0003e;99% inhibition at &#x0003c;25 &#x003bc;M) was also demonstrated with DN59. However, a potent WNV inhibitory peptide, WN83, which corresponds to WNV E domain IIb, did not inhibit infectivity by DENV. Additional results suggest that these inhibitory peptides are noncytotoxic and act in a sequence specific manner. The inhibitory peptides identified here can serve as lead compounds for the development of peptide drugs for flavivirus infection.</p><div id="__sec1" class="sec"><h3 id="__sec1title">Electronic supplementary material</h3><p id="__p2" class="p p-first-last">The online version of this article (doi:10.1186/1743-422X-2-49) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">West Nile Virus, Japanese Encephalitis Virus, Inhibitory Peptide, Dengue Hemorrhagic Fever, Fusion Peptide</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="__p3" class="p p-first">Enveloped viruses utilize membrane-bound fusion proteins to mediate attachment and entry into specific target host cells. During the virion assembly process, newly synthesized envelope proteins are targeted to the endoplasmic reticulum and golgi apparatus where initial folding and post-transcriptional processing occurs, including multimerization, glycosylation, and proteolysis. This initial folding and processing is required to achieve a conformation where the proteins are held in a metastable state prior to virion release. Post virion release, the multimeric envelope proteins are poised to undergo structural rearrangement leading to fusion of the virion and the new target cell lipid bilayer membranes. Depending on the virus system, the rearrangement trigger can take the form of specific receptor binding, multiple receptor binding, decreased pH following receptor mediated endocytosis, or a combination of triggers.</p><p id="__p4">The prototypic viral envelope fusion protein, the hemagglutinin of influenza virus, contains short alpha helical domains in the trimeric virion configuration. In response to receptor binding and decreased pH, the short helices rearrange with adjoining sequences to produce a longer helix, thus exposing an N-terminal fusion peptide that is believed to interact directly with the target cell membrane. This is followed by a hinge-like bending of the entire complex to adjoin and fuse the two lipid membranes [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725864">2</a>, <a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725870">3</a>]. The structural rearrangements that result in extrusion of the fusion peptide and subsequent collapse involve alterations in packing between regions both within individual fusion proteins as well as between monomeric subunits in the trimeric structures. Several disparate viruses, including arenaviruses, coronaviruses, filoviruses, orthomyxoviruses, paramyxoviruses and retroviruses, encode similar proteins that together are classified as class I fusion proteins. These class I viral fusion proteins vary in length and sequence, but are similar in overall structure [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248690">4</a>, <a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725859">5</a>].</p><p id="__p5">Qureshi et al. (1990) demonstrated that a peptide from one of the two extended helical domains of the HIV-1 transmembrane protein can block virion infectivity. Subsequently, the FDA approved anti-HIV-1 drug Fuzeon&#x02122; (aka DP178, T-20, enfuvirtide) and other N- and C-helix inhibitory peptides were developed [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725849">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725851">7</a>]. These results have greatly motivated the search for other HIV-1 inhibitory peptides [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725868">8</a>, <a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725858">9</a>]. Additional peptide mimics of the fusion proteins of other retroviruses, and of orthomyxoviruses, paramyxoviruses, filoviruses, coronaviruses, and herpesviruses have also been identified and shown to inhibit viral entry [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725866">10</a>&#x02013;<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725857">18</a>]</p><p id="__p6">The envelope fusion proteins of several virus types, including the flaviviruses and alphaviruses, have a structure distinct from class I viral fusion proteins. The envelope glycoprotein (E) of the flavivirus tick-borne encephalitis virus (TBEV) consists of three domains: a structurally central amino terminal domain (domain I), a dimerization domain (domain II) and a carboxyl terminal Ig-like domain (domain III), all containing predominantly beta sheet folds [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725856">19</a>]. The primary sequence of E1, the fusion protein of Semliki Forest virus, an alphavirus, revealed a remarkable fit to the scaffold of TBEV E [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725838">20</a>] suggesting the existence of a second class of viral fusion proteins. The dengue virus (DENV) E protein has also been shown to have a class II structure [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725840">21</a>]. Recent studies of flavivirus virions and proteins by cryoelectron microscopy and crystal structure analysis have lead to a greatly increased understanding of the function of these class II viral envelope proteins, including the structural rearrangements they undergo during maturation, triggering and fusion [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725842">21</a>&#x02013;<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725865">28</a>].</p><p id="__p7">The flaviviruses, which include DENV, West Nile virus (WNV), yellow fever virus, Japanese encephalitis virus (JEV), and TBEV, among others, are transmitted between vertebrate hosts by insect vectors. The most serious manifestations of DENV infection are dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). There are four serotypes of DENV (1&#x02013;4), which together cause an estimated 50 million human infections per year [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248691">29</a>], and each can cause DF, DHF or DSS. Because of the phenomenon of antibody-dependent enhancement (ADE), or other immune phenomena, protection against one DENV serotype increases the risk of DHF or DSS when the individual is exposed to another serotype [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725837">30</a>&#x02013;<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725848">32</a>]. Cross-reactive, but non-neutralizing antibodies can mediate entry of DENV into macrophages, dendritic cells and other viral target cells via Fc receptors, increasing virus titers and thus pathology. Multivalent DENV vaccines have shown some promise in humans [<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725836">32</a>&#x02013;<a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725839">39</a>] and in nonhuman primate studies [<a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725841">40</a>, <a href="#CR41" rid="CR41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725874">41</a>], but face several obstacles. Antiviral drugs, which target each of the four serotypes of DENV without enhancing pathogenesis of any serotype, are urgently needed. The recent introduction of WNV in the United States further highlights the public health challenges posed by flaviviruses. No effective vaccine or antiviral drug therapy is currently available against either DENV or WNV.</p><p id="__p8" class="p p-last">Although there are many differences between the structures of class I and class II viral fusion proteins, we hypothesized that they function through a similar membrane fusion mechanism involving rearrangements of domains, and that peptides mimicking portions of class II viral fusion proteins would inhibit virion fusion and entry steps thereby serving as lead compounds for the development of antivirals. We used a physio-chemical algorithm, the Wimley-White interfacial hydrophobicity scale [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>] in combination with known structural data to predict regions of the DENV and WNV E proteins that may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process. Several of these peptides specifically inhibit DENV or WNV infection.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Identification of Flavivirus inhibitory peptides</h3><p id="__p9" class="p p-first">The domains that precede the transmembrane anchors of most class I fusion proteins are not highly hydrophobic, however, they usually contain a cluster of aromatic amino acids and display a tendency to partition into bilayer membranes, as revealed by analyses using the experimentally-determined Wimley-White interfacial hydrophobicity scale (WWIHS) [<a href="#CR42" rid="CR42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725862">42</a>]. Fuzeon\'s corresponding sequence overlaps the aromatic pre-anchor domain of HIV-1 TM. Synthetic peptides corresponding to other domains of class I viral fusion proteins with significant WWIHS scores may also inhibit viral infectivity [<a href="#CR43" rid="CR43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725855">43</a>]. Previously, we suggested that peptide drugs analogous to Fuzeon might be developed for HCV and other members of the Flaviviridae [<a href="#CR44" rid="CR44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725850">44</a>]. DENV E contains five domains with significant WWIHS scores (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1,</span></span><span>1</span></a>, WWIHS sequences in black). These include the fusion peptide domain, a portion of subdomain IIb, the pre-anchor stem region following domain III, and the transmembrane domain. Sequences with high WWIHS scores are similarly located in the X-ray structures of WNV E and alphavirus (SFV and Sindbis virus &#x02013; SINV) E1, and potentially also in the putative class II fusion proteins of hepatitis C virus (HCV), pestiviruses and bunyaviruses [<a href="#CR44" rid="CR44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725853">44</a>, <a href="#CR45" rid="CR45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725852">45</a>]. Regions with high WWIHS scores are predicted to play a role in protein-protein interactions during structural rearrangements or protein-lipid interactions during bilayer fusion, and we predicted that synthetic peptides corresponding to these regions may have the potential to inhibit flavivirus infectivity.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC1177995/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190417430096" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig1_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig1_HTML.jpg" /></div><div id="largeobj_idm140190417430096" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p10"><strong>Diagramatic structure of DENV envelope protein showing inhibitory peptide regions</strong>. Grey lines: dicysteine linkages. Black stick figures: N-glycosylation sites. Regions with significant Wimley-White interfacial hydrophobicity scale scores were predicted with MPeX (Boxed in left depiction; black in right depiction). Sequences of DENV peptides and the location of WNV homologs are indicated.</p></div></div></div><p id="__p11" class="p p-last">To test this hypothesis, an initial set of synthetic peptides representing sequences of DENV E and WNV E with significant WWIHS scores was synthesized and screened for the ability to inhibit plaque formation by these flaviviruses (Table <a href="/pmc/articles/PMC1177995/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Peptides corresponding to the transmembrane domain were not tested because this region is not exposed during the entry process. Initial assays for inhibitory activity were performed using the highest concentration of each peptide that could be obtained in aqueous solution with a maximum of 1% DMSO (between 29 and 128 &#x003bc;M). Plaque reduction in which the inhibitor is removed after virus adsorption is the most stringent test of an antiviral agent. Prior to initiating these studies, we developed a new immunoplaque assay for DENV and WNV. Approximately 200 focus forming units (FFU) of either WNV or DENV were preincubated with each of the peptides and used to infect monolayers of LLCKM-2 monkey kidney epithelial cells. The number of resulting viral foci was determined from three experiments and normalized to a no-peptide control to calculate the percent inhibition. Our screening of this initial set detected several peptides that were able to inhibit infection by DENV or WNV (Table <a href="/pmc/articles/PMC1177995/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1,</span></span><span>1</span></a>, Fig. <a href="/pmc/articles/PMC1177995/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.2).</span></span><span>2</span></a>). Peptides similar in sequence to domains with a significant WWIHS scores, including domain II (IIb) (WN53 and WN83), and stem domain (DN59), were found to have inhibitory activity.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p12">Initial peptides synthesized and tested for inhibitory activity.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190341785712" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Peptide</th><th align="center" rowspan="1" colspan="1">Sequence</th><th align="center" rowspan="1" colspan="1">Location<sup>a</sup></th><th align="center" rowspan="1" colspan="1">Concentration (&#x003bc;M)</th><th align="center" rowspan="1" colspan="1">% Inhibition +/- SD</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DN80</td><td align="left" rowspan="1" colspan="1">MVDRGWGNHAGLFGKGSIV</td><td align="center" rowspan="1" colspan="1">386&#x02013;400</td><td align="center" rowspan="1" colspan="1">49.9</td><td align="center" rowspan="1" colspan="1">17 +/- 10</td></tr><tr><td align="left" rowspan="1" colspan="1">DN57</td><td align="left" rowspan="1" colspan="1">AWLVHTQWFLDLPLPWLPGADTQGSNWI</td><td align="center" rowspan="1" colspan="1">485&#x02013;503</td><td align="center" rowspan="1" colspan="1">30.6</td><td align="center" rowspan="1" colspan="1">7 +/- 4</td></tr><tr><td align="left" rowspan="1" colspan="1">DN81</td><td align="left" rowspan="1" colspan="1">AWLVHRQWFLDLPLPWLPG</td><td align="center" rowspan="1" colspan="1">485&#x02013;512</td><td align="center" rowspan="1" colspan="1">42.6</td><td align="center" rowspan="1" colspan="1">25 +/- 8</td></tr><tr><td align="left" rowspan="1" colspan="1">DN59</td><td align="left" rowspan="1" colspan="1">MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY</td><td align="center" rowspan="1" colspan="1">692&#x02013;724</td><td align="center" rowspan="1" colspan="1">29.0</td><td align="center" rowspan="1" colspan="1">93 +/- 2</td></tr><tr><td align="left" rowspan="1" colspan="1">WN82</td><td align="left" rowspan="1" colspan="1">VVDRGWGNGAGLFGKGSID</td><td align="center" rowspan="1" colspan="1">396&#x02013;410</td><td align="center" rowspan="1" colspan="1">52.5</td><td align="center" rowspan="1" colspan="1">4 +/- 13</td></tr><tr><td align="left" rowspan="1" colspan="1">WN53</td><td align="left" rowspan="1" colspan="1">TFLVHREWFMDLNLPWSSAGSTVWR</td><td align="center" rowspan="1" colspan="1">500&#x02013;518</td><td align="center" rowspan="1" colspan="1">98.7</td><td align="center" rowspan="1" colspan="1">56 +/- 5</td></tr><tr><td align="left" rowspan="1" colspan="1">WN83</td><td align="left" rowspan="1" colspan="1">TFLVHREWFMDLNLPWSSA</td><td align="center" rowspan="1" colspan="1">500&#x02013;524</td><td align="center" rowspan="1" colspan="1">128.0</td><td align="center" rowspan="1" colspan="1">70 +/- 2</td></tr></tbody></table></div><div id="largeobj_idm140190341785712" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p13"><sup>a</sup> numbering from the beginning of the E polyprotein in either DENV or WNV.</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC1177995/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190327820864" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig2_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig2_HTML.jpg" /></div><div id="largeobj_idm140190327820864" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p14"><strong>Plaque inhibition assay</strong>. (A) Preincubation of DENV with neutralizing antiserum reduces plaque number by 74%. (B) Preincubation of DENV with a non-inhibitory peptide shows no reduction in plaques. (C) Preincubation of DENV with one of the inhibitory peptides (DN59) shows a greater than 95% reduction in plaques.</p></div></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Determination of 50% inhibitory concentrations</h3><p id="__p15" class="p p-first-last">Dose-response curves were determined for the most potent of the peptides WN53 and WN83 against WNV and also for peptide DN59 against DENV (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3).</span></span><span>3</span></a>). The WN53 peptide showed a maximum inhibitory activity against WNV of 56.0 +/- 3.0% (mean +/- SD) at 99 &#x003bc;M. The inhibitory activity decreased with decreasing concentration with a 50% inhibitory concentration (IC50) at roughly 10 &#x003bc;M. The WN83 peptide showed a maximum inhibitory activity against WNV of 70.0 +/- 3.0% at 128 &#x003bc;M. The inhibitory activity decreased with decreasing concentration with an IC50 of roughly 10 &#x003bc;M. The DN59 peptide showed a maximum inhibitory activity against DENV of 100.0 +/- 0.5% at 20 &#x003bc;M. The inhibitory activity decreased with decreasing concentration with an IC50 of at roughly 10 &#x003bc;M. DENV stem peptide 59 (DN59) and WNV peptides 53 and 83 (WN53, WN83) reproducibly inhibited infectivity at low &#x003bc;M concentrations.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC1177995/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190346099136" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig3_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig3_HTML.jpg" /></div><div id="largeobj_idm140190346099136" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p16"><strong>Dose-response curves for WN53, WN83 and DN59 peptides</strong>. (A) Increasing concentrations of peptide WN53 produce a corresponding increase in WNV inhibition with an IC50 in the 10&#x003bc; range. (B) Increasing concentrations of peptide WN83 produce a corresponding increase in WNV inhibition with an IC50 in the 10 &#x003bc;M range. (C) Increasing concentrations of peptide DN59 also produce a corresponding increase in DNV inhibition with an IC50 in the 10 &#x003bc;M range. All measurements were made in triplicate, with mean +/- SD shown.</p></div></div></div></div><div id="Sec5" class="sec"><h3 id="Sec5title">Specificity of peptide inhibitory activity</h3><p id="__p17" class="p p-first">The DN59 peptide matches a pre-anchor domain sequence that is highly conserved among insect-transmitted flaviviruses. DN59 inhibited infection by DENV (&#x0003e;99% inhibition of plaque formation at a concentrations of &#x0003c;25 &#x003bc;M). Cross-inhibition of WNV fusion/infectivity (&#x0003e;99% inhibition at &#x0003c;25 &#x003bc;M) was also reproducibly demonstrated with DN59 (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6).</span></span><span>6</span></a>). However, WNV inhibitory peptide WN83 did not inhibit infectivity by DENV.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC1177995/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190343360976" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig6_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig6_HTML.jpg" /></div><div id="largeobj_idm140190343360976" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p18"><strong>Inhibitory effect of peptides WN53 and DN59 alone and in combination</strong>. WN53 and DN59 peptides were tested alone (&#x025a0; DN59 alone, &#x025cf; WN53 alone) or together (&#x025c6;) with WNV and inhibitory activity at three concentrations was measured (mean of three trials +/- SD shown). DN59 and WN53 together have an effect intermediate between the two peptides alone.</p></div></div></div><p id="__p19" class="p p-last">To determine if these peptides specifically inhibit infectivity of the viruses for which they were designed, the WN53, WN83 and DN59 peptides were tested for inhibitory effects against Sindbis virus (SINV), an alphavirus that encodes a class II fusion protein. None of the peptides showed a statistically significant effect against SINV infectivity (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4).</span></span><span>4</span></a>). Peptides with the same amino acid composition as WN83 and DN59, but a scrambled sequence (Scrambled WN83: VATWHLDWSREFPLFLMNS; Scrambled DN59: YFIDTSGAIWGASHLTGVLFDFMGIQGGAVLAK) were synthesized and tested for the ability to inhibit infection by WNV and DENV respectively. Neither scrambled peptide significantly inhibited infection by these viruses (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5).</span></span><span>5</span></a>). These results provide evidence that the action of these inhibitory peptides not due to general inactivation of enveloped virions and is sequence specific.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC1177995/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190340872064" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig4_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig4_HTML.jpg" /></div><div id="largeobj_idm140190340872064" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p20"><strong>Effect of DENV and WNV specific peptides against another virus</strong>. Peptides DN59, WN83 and WN53 at 100 &#x003bc;g/ml concentrations were tested for inhibitory activity against the alphavirus SINV in a similar plaque reduction assay. Results are shown as the mean of three trials +/- SEM. None of the peptides showed a statistically significant inhibitory effect against SINV (ANOVA, p = 0.705, with Dunnett\'s posthoc test).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC1177995/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190418791520" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig5_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig5_HTML.jpg" /></div><div id="largeobj_idm140190418791520" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p21"><strong>Effect of scrambled peptide order on inhibitory function</strong>. Scrambled versions of peptides DN59 and WN83 at 100 &#x003bc;g/ml concentrations were tested for inhibitory effect against DENV and WNV, respectively. Scrambled versions of the peptides showed no inhibitory activity compared to the original DN59 and WN83 peptides.</p></div></div></div></div><div id="Sec6" class="sec"><h3 id="Sec6title">Peptide toxicity</h3><p id="__p22" class="p p-first-last">It is possible that inhibitory peptides induce cellular alterations or toxicity that can block flavivirus entry or other steps in the replication cycle. To address this possibility, LLCMK-2 monkey kidney epithelial cell monolayers were exposed to 100 mg/ml concentrations of WN53, WN83 and DN59 peptides for 24 hrs, and cell viability was assayed with an MTT assay. No statistical difference was observed between the viability of control cells versus cells exposed to the peptides or DMSO (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.7).</span></span><span>7</span></a>). This result suggests that these inhibitory peptides are not blocking infectivity via effects on host cell metabolism or viability.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC1177995/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190336918320" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig7_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2005_Article_64_Fig7_HTML.jpg" src="/pmc/articles/PMC1177995/bin/12985_2005_Article_64_Fig7_HTML.jpg" /></div><div id="largeobj_idm140190336918320" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC1177995/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Figure 7</a></div><!--caption a7--><div class="caption"><p id="__p23"><strong>Toxicity of inhibitory peptides in cell culture</strong>. MTT assays for cell viability were performed after 24 hr incubation of cells with 100 &#x003bc;g/ml of peptides WN83, WN53, and DN59 (mean from three experiments +/- SEM). No statistically significant differences in cell viability were observed (ANOVA p = 0.672, with Dunnett\'s posthoc test).</p></div></div></div></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title">Non-synergistic activity of combined peptides</h3><p id="__p24" class="p p-first-last">When added in combination, peptides that block entry at different steps or that target different domains may produce greater inhibition of DENV-2 infectivity than either peptide alone. Synergistic or antagonistic effects are also possible, if a peptide that alters protein-protein interactions allows greater or lesser access to E domains targeted by another peptide. Since the WN53, WN83 and DN59 peptides all inhibited WNV entry, the possibility of antagonistic or synergistic function was examined by testing WN53 and DN59 alone or in combination at three concentrations (5, 10 and 20 &#x003bc;M). At all three concentrations, the peptide combination was more effective than WN53 alone, but less effective than DN59 alone. This indicates that the activity of the WN53 peptide has an antagonistic effect on the function of the DN59 peptide (Fig. <a href="/pmc/articles/PMC1177995/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6</span></span><span>6</span></a>).</p></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Discussion</h2><p id="__p25" class="p p-first">Synthetic peptides corresponding to sequences in DENV and WNV E proteins were identified that inhibited infectivity of these viral pathogens of major public health importance. The inhibitory effects of these peptides were dose dependent with IC50s in the range of 10 &#x003bc;M. Several of the most potent of these peptides showed no inhibitory activity against SINV, an alphavirus that possesses a class II viral fusion protein with a similar overall structure as flavivirus E. Scrambled peptides with the same amino acid composition as the inhibitory peptides, but with a different primary sequence, failed to inhibit DENV and WNV infection. None of the DENV or WNV inhibitory peptides induced gross cytopathic effects, killing of cultured cells or showed evidence of <em>in vitro</em> cellular toxicity. These results indicate that these inhibitory peptides function through a sequence-specific mechanism and are not merely cytotoxic.</p><p id="__p26">Membrane fusion by both class I and II viral fusion proteins is initiated by interaction of the fusion peptide with the target cell membrane. In class I viral fusion proteins, a subsequent rearrangement of a trimer of the proteins, each with two &#x003b1; helices, to form a six-helix bundle brings the viral and cell membranes into closer proximity. Inhibitors of viruses with class I fusion proteins, such as Fuzeon&#x02122; that mimic a portion of one or the other of the two &#x003b1; helices, interfere with a step proximal to six-helix bundle formation possibly by forming an inactive aggregate with the opposite helix. Recent studies indicate that after insertion of the fusion peptide, class II viral fusion proteins likewise undergo rearrangements. In this case, intraprotein interactions may occur between the stem domain and domains I, II and/or III [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725860">21</a>&#x02013;<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725872">28</a>, <a href="#CR46" rid="CR46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725844">46</a>]. According to this model, the viral and cellular membranes are brought closer by interactions of the stem with other portions of E, resulting in bilayer fusion. DN59, WN53 and WN83 peptides may interfere with the intramolecular interactions between the stem and other portions of class II viral fusion proteins, a possibility suggested previously [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725863">23</a>, <a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725834">24</a>, <a href="#CR46" rid="CR46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725847">46</a>].</p><p id="__p27">Two of the inhibitory peptides (WN53 and WN83) are designed from overlapping regions of the E protein domain I/II junction and are specifically inhibitory against WNV. Recently, other investigators have hypothesized that small molecule inhibitors to this domain I/II junction region might be developed. Modis et al (2003; 2004) predicted that interactions near this region (the k-l loop) that are involved in the rotational changes between these domains might be blocked by small molecule inhibitors. However, our similar peptides designed from the analogous region of the DENV E protein (D57 and D81) failed to inhibit DENV infectivity.</p><p id="__p28">The possibility that WN53, WN83 and DN59 interact with some target cell surface component to exert their inhibitory effects cannot be ruled out. However, the majority of flavivirus neutralizing antibodies that appear to be involved in receptor blocking bind to domain III, and soluble domain III itself can block flavivirus entry, apparently through competition for cellular receptors [<a href="#CR47" rid="CR47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725869">47</a>&#x02013;<a href="#CR51" rid="CR51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248689">51</a>]. In contrast, the domains that correspond to WN53, WN83 and DN59 peptides, IIb and the pre-anchor stem, appear to be involved in structural rearrangements during fusion, rather than direct interactions with cellular receptors. Interestingly, previous observations indicate that some monoclonal antibodies block virion entry at a post attachment step, indicating that they may interfere with conformational changes necessary for fusion [<a href="#CR52" rid="CR52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725843">52</a>]. That possibility that some antibodies can gain access to regions important for conformational changes and block these changes suggests that these inhibitory peptide regions might be candidates for novel vaccine designs that either utilize the inhibitory peptide regions directly as antigens, or target the regions that interact with the inhibitory peptides. Further studies are needed to define the exact mechanism of inhibition of these DENV and WNV peptides, and the specific nature or location of their interactions with viral targets.</p><p id="__p29">The DN59 peptide is inhibitory against DENV as well as WNV. The corresponding pre-anchor region is highly conserved between DENV and WNV as well as among other flaviviruses (Table <a href="/pmc/articles/PMC1177995/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2)</span></span><span>2</span></a>) and probably functions in a similar manner during entry of all flaviviruses [<a href="#CR53" rid="CR53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725835">53</a>]. Thus, DN59 or similar peptides may act as broad-spectrum flavivirus inhibitors. Other flaviviruses considered potential bioterrorism agents, including JEV, Kyasanur Forest disease virus and TBEV, may also be inhibited by DN59, a DN59 derivative, or by an analogous peptide. Unlike proposed DENV vaccines, which must be multivalent (ie. simultaneously effective against each of the four DENV serotypes because of the phenomenon of antibody dependent enhancement), peptide drugs targeting the highly conserved stem conserved motifs in flavivirus E may demonstrate cross-strain efficacy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p30">Alignment of preanchor domain sequences from representative flaviviruses.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140190346301632" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">\n<em>Virus</em>\n<sup><em>a</em></sup>\n</th><th align="left" rowspan="1" colspan="1">\n<em>Pre-anchor sequence</em>\n<sup><em>b</em></sup>\n</th><th align="left" rowspan="1" colspan="1">\n<em>Location</em>\n<sup><em>c</em></sup>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;DENV-1</td><td align="left" rowspan="1" colspan="1">AILGDTAWDFGSIGGVFTSVGKLIHQIFGTA</td><td align="center" rowspan="1" colspan="1">693&#x02013;723</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;DENV-2</td><td align="left" rowspan="1" colspan="1">AILGDTAWDFGSLGGVFTSIGKALHQVFGAI</td><td align="center" rowspan="1" colspan="1">693&#x02013;723</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;DENV-3</td><td align="left" rowspan="1" colspan="1">AILGDTAWDFGSVGGVLNSLGKMVHQIFGSA</td><td align="center" rowspan="1" colspan="1">691&#x02013;721</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;DENV-4</td><td align="left" rowspan="1" colspan="1">AILGETAWDFGSVGGVLTSLGKAVHQVFGSV</td><td align="center" rowspan="1" colspan="1">692&#x02013;722</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;WNV</td><td align="left" rowspan="1" colspan="1">AVLGDTAWDFGSVGGVFTSVGKAVHQVFGGA</td><td align="center" rowspan="1" colspan="1">709&#x02013;739</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;YFV</td><td align="left" rowspan="1" colspan="1">AVMGDTAWDFSSAGGFFTSVGKGIHTVFGSA</td><td align="center" rowspan="1" colspan="1">695&#x02013;725</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;SLEV</td><td align="left" rowspan="1" colspan="1">AVLGDTAWDFGSIGGVFTSIGKALHQVFGGA</td><td align="center" rowspan="1" colspan="1">707&#x02013;737</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;JEV</td><td align="left" rowspan="1" colspan="1">AALGDTAWDFGSIGGVFNSIGKAVHQVFGGA</td><td align="center" rowspan="1" colspan="1">712&#x02013;742</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;TBEV</td><td align="left" rowspan="1" colspan="1">TVIGEHAWDFGSAGGFLSSIGKAVHTVLGGA</td><td align="center" rowspan="1" colspan="1">694&#x02013;724</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;OHFV</td><td align="left" rowspan="1" colspan="1">TVLGEHAWDFGSTGGFLSSIGKALHTVLGGA</td><td align="center" rowspan="1" colspan="1">694&#x02013;724</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;KFV</td><td align="left" rowspan="1" colspan="1">TVVGEHAWDFGSVGGMLSSVGKALHTAFGAA</td><td align="center" rowspan="1" colspan="1">695&#x02013;725</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;POWV</td><td align="left" rowspan="1" colspan="1">SVVGEHAWDFGSVGGVLSSVGKAIHTVLGGA</td><td align="center" rowspan="1" colspan="1">693&#x02013;723</td></tr></tbody></table></div><div id="largeobj_idm140190346301632" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1177995/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p31"><sup>a</sup>DENV: dengue virus; WNV: West Nile virus; YFV: yellow fever virus; SLEV: St. Louis encephalitis virus; JEV: Japanese encephalitis virus; TBEV: Tick-borne encephalitis virus; OHFV: Omsk hemorrhagic fever virus; KFV: Kyasanur Forest virus; POWV: Powassan virus</p><p id="__p32"><sup>b</sup> * = identical or chemically similar amino acids in every sequence</p><p id="__p33"><sup>c</sup>numbering from the beginning of the E polyprotein.</p></div></div><p id="__p34">IC50s in the &#x003bc;M range have been considered promising for class I viral fusion protein inhibitor development [<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725846">54</a>, <a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725845">55</a>]. Thus, the peptides identified here can serve as lead compounds that may be developed as peptide drugs against the four serotypes of DENV, WNV and potentially other flaviviruses. We anticipate that such peptide inhibitors may be as successful as the HIV-1 inhibitory peptide Fuzeon&#x02122;. Unlike persistant HIV infections, immune responses against DENV and other flaviviruses are capable of clearing the viruses in individuals that survive the initial infection. By reducing the viral load during the initial stages of infection, it may be possible to extend the window of time during which an immune response could arise, and thus enable more individuals to control, eliminate and survive infections by these agents. Evidence for the ability to therapeutically intervene in flavivirus-induced diseases has been demonstrated with the recent observation that administration of neutralizing antibodies against WNV can be curative, even after symptom initiation [<a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725871">56</a>]. Development of resistant mutants will be a concern, but should be a less problematic than in the case of long-term treatment of persistent retroviral infections.</p><p id="__p35" class="p p-last">It is worth noting that the HIV inhibitor Fuzeon&#x02122;, was initially identified using a predictive strategy without the availability of structural data [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725861">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725867">7</a>, <a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844725873">57</a>]. The fact that we developed these peptides using a predictive algorithm validates our approach as well as the accuracy of the flavivirus E protein structural data. A similar approach may be useful for the large number of other viruses with class II envelope fusion proteins with or without known structures.</p></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Materials and methods</h2><div id="Sec10" class="sec sec-first"><h3 id="Sec10title">Design and synthesis of peptides</h3><p id="__p36" class="p p-first-last">Sequences of DENV and WNV E with positive Wimley-White interfacial hydrophobicity scale scores were determined using the program Membrane Protein eXplorer [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]. After consideration of the known secondary structures for several subdomains of E, selected peptides were synthesized by solid-phase conventional N-&#x003b1;-9-flurenylmethyloxycarbonyl chemistry (Genemed Synthesis, San Francisco, CA). Peptides were purified by reverse-phase high performance liquid chromatography and confirmed by amino acid analysis and electrospray mass spectrometry. Peptide stock solutions were prepared in 20% (v/v) dimethyl sulfoxide (DMSO): 80% (v/v) H<sub>2</sub>0, and concentrations determined by absorbance of aromatic side chains at 280 nm. Scrambled peptides sequences were obtained by drawing from a hat.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Viruses and Cells</h3><p id="__p37" class="p p-first-last">DENV strain New Guinea-2 and WNV strain Egypt 101 were obtained from R. Tesh at the World Health Organization Arbovirus Reference Laboratory at the University of Texas at Galveston. DENV and WNV were propagated in the African green monkey kidney epithelial cell line, LLCKM-2, a gift of K. Olsen at Colorado State University. Sindbis virus (SINV) containing the enhanced green fluorescent protein (EGFP) protein expression cassette was obtained from K. Ryman at Louisiana State University at Shreveport and was propagated in baby hamster kidney cells. All cells were grown in Dulbecco\'s modified eagle medium (DMEM) with 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin G and 100 mg/ml streptomycin, at 37&#x000b0;C with 5% (v/v) CO<sub>2</sub>.</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Viral plaque reduction assays</h3><p id="__p38" class="p p-first-last">LLCKM-2 target cells were seeded at a density of 3 &#x000d7; 10<sup>5</sup> cells in each well of a 6-well plate 48 h prior to infection. Approximately 200-focus forming units (FFU) of DENV, WNV, or SINV/EGFP were incubated with or without peptides in serum-free DMEM for 1 h at rt. Virus/peptide or virus/control mixtures were allowed to infect confluent LLCKM-2 monolayers for 1 h at 37&#x000b0;C, after which time the medium was removed and the cells were washed once with phosphate buffered saline (PBS) and overlaid with fresh DMEM/10% (v/v) FBS containing 0.85% (w/v) SeaPlaque Agarose (Cambrex Bio Science, Rockland, ME). Cells were then incubated at 37&#x000b0;C with 5% CO<sub>2</sub> for 1 day (Sindbis virus), 3 days (WNV) or 6 days (DNV). Sindbis virus infections were quantified by directly counting green fluorescing foci. Cultures infected with DENV were fixed with 10% formalin overnight at 4&#x000b0;C and permeablized with 70% (v/v) ethanol prior to immunostaining and visualization using a human polyclonal anti-flavivirus antibody (a gift of V. Vorndam, CDC, San Juan) followed by horseradish peroxidase (HRP) conjugated goat anti-human immunoglobulin (Pierce, Rockford, IL) and AEC chromogen substrate (Dako, Carpinteria, CA). WNV plaques were similarly visualized using a mouse anti-WNV antibody (Chemicon, Temecula, CA) and an HRP conjugated goat anti-mouse antibody (Dako, Carpinteria, CA).</p></div><div id="Sec13" class="sec sec-last"><h3 id="Sec13title">Toxicity assay</h3><p id="__p39" class="p p-first-last">Peptide cytotoxicity was measured using the TACS&#x02122; MTT cell proliferation assay (R&#x00026;D systems, Minneapolis, MN) according to the manufacturer\'s instructions.</p></div></div><div id="idm140190340029888" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140190340029888title">Acknowledgements</h2><div class="sec"><p id="__p48">The authors would like to thank S. Isern, B. Sainz, W. Wimley and W. Gallaher for helpful discussions and technical assistance.</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec14" class="sec sec-first"><h3 id="Sec14title">Authors&#x02019; original submitted files for images</h3><p id="__p40" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM1_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(902K, jpeg)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM2_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(670K, tiff)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM3_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(179K, jpeg)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM4_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(62K, jpeg)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM5_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(38K, jpeg)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM6_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(21K, jpeg)</sup></span><span class="sup-box" id="MOESM7"><a href="/pmc/articles/PMC1177995/bin/12985_2005_64_MOESM7_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 7</a><sup>(72K, jpeg)</sup></span></p></div></div><div id="idm140190337551152aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140190337551152aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Yancey M Hrobowski, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.enalut@swoborhy" class="oemail">ude.enalut@swoborhy</a></span>.</p><p><span class="fm-affl">Robert F Garry, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.enalut@yrragfr" class="oemail">ude.enalut@yrragfr</a></span>.</p><p><span class="fm-affl">Scott F Michael, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ucgf@leahcims" class="oemail">ude.ucgf@leahcims</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">White SH, Snider C, Jaysinghe S, Kim J.  <span class="ref-journal">http://blancobiomoluciedu/mpex/</span> 2003. Membrane Protein Explorer version 2.2a. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=http://blancobiomoluciedu/mpex/&amp;author=SH+White&amp;author=C+Snider&amp;author=S+Jaysinghe&amp;author=J+Kim&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Carr CM, Kim PS. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. <span><span class="ref-journal">Cell. </span>1993;<span class="ref-vol">73</span>:823\xe2\x80\x93832. doi: 10.1016/0092-8674(93)90260-W.</span> [<a href="/pubmed/8500173" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0092-8674(93)90260-W" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=A+spring-loaded+mechanism+for+the+conformational+change+of+influenza+hemagglutinin&amp;author=CM+Carr&amp;author=PS+Kim&amp;volume=73&amp;publication_year=1993&amp;pages=823-832&amp;pmid=8500173&amp;doi=10.1016/0092-8674(93)90260-W&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. <span><span class="ref-journal">Nature. </span>1981;<span class="ref-vol">289</span>:366\xe2\x80\x93373. doi: 10.1038/289366a0.</span> [<a href="/pubmed/7464906" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F289366a0" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure+of+the+haemagglutinin+membrane+glycoprotein+of+influenza+virus+at+3+A+resolution&amp;author=IA+Wilson&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=289&amp;publication_year=1981&amp;pages=366-373&amp;pmid=7464906&amp;doi=10.1038/289366a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Gallaher WR. Similar structural models of the transmembrane glycoproteins of Ebola and avian sarcoma viruses. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">85</span>:1\xe2\x80\x932. doi: 10.1016/S0092-8674(00)81248-9.</span> [<a href="/pubmed/8653783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0092-8674(00)81248-9" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Similar+structural+models+of+the+transmembrane+glycoproteins+of+Ebola+and+avian+sarcoma+viruses&amp;author=WR+Gallaher&amp;volume=85&amp;publication_year=1996&amp;pages=1-2&amp;pmid=8620528&amp;doi=10.1016/S0092-8674(00)81248-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Gallaher WR, Ball JM, Garry RF, Griffin MC, Montelaro RC. A general model for the transmembrane proteins of HIV and other retroviruses. <span><span class="ref-journal">AIDS Res Hum Retroviruses. </span>1989;<span class="ref-vol">5</span>:431\xe2\x80\x93440. doi: 10.1089/aid.1989.5.431.</span> [<a href="/pubmed/2788443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1089%2Faid.1989.5.431" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS+Res+Hum+Retroviruses&amp;title=A+general+model+for+the+transmembrane+proteins+of+HIV+and+other+retroviruses&amp;author=WR+Gallaher&amp;author=JM+Ball&amp;author=RF+Garry&amp;author=MC+Griffin&amp;author=RC+Montelaro&amp;volume=5&amp;publication_year=1989&amp;pages=431-440&amp;pmid=2788443&amp;doi=10.1089/aid.1989.5.431&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1994;<span class="ref-vol">91</span>:9770\xe2\x80\x939774. doi: 10.1073/pnas.91.21.9770.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC44898/">PMC free article</a>]</span> [<a href="/pubmed/7937889" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.91.21.9770" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Peptides+corresponding+to+a+predictive+alpha-helical+domain+of+human+immunodeficiency+virus+type+1+gp41+are+potent+inhibitors+of+virus+infection&amp;author=CT+Wild&amp;author=DC+Shugars&amp;author=TK+Greenwell&amp;author=CB+McDanal&amp;author=TJ+Matthews&amp;volume=91&amp;publication_year=1994&amp;pages=9770-9774&amp;pmid=7937889&amp;doi=10.1073/pnas.91.21.9770&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Wild C, Greenwell T, Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. <span><span class="ref-journal">AIDS Research &#x00026; Human Retroviruses. </span>1993;<span class="ref-vol">9</span>:1051\xe2\x80\x931053. doi: 10.1089/aid.1993.9.1051.</span> [<a href="/pubmed/8312047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1089%2Faid.1993.9.1051" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS+Research+&#x00026;+Human+Retroviruses&amp;title=A+synthetic+peptide+from+HIV-1+gp41+is+a+potent+inhibitor+of+virus-mediated+cell-cell+fusion&amp;author=C+Wild&amp;author=T+Greenwell&amp;author=T+Matthews&amp;volume=9&amp;publication_year=1993&amp;pages=1051-1053&amp;pmid=8312047&amp;doi=10.1089/aid.1993.9.1051&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Pozniak A. HIV fusion inhibitors. <span><span class="ref-journal">J HIV Ther. </span>2001;<span class="ref-vol">6</span>:91\xe2\x80\x9394.</span> [<a href="/pubmed/11740409" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+HIV+Ther&amp;title=HIV+fusion+inhibitors&amp;author=A+Pozniak&amp;volume=6&amp;publication_year=2001&amp;pages=91-94&amp;pmid=11740409&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Sodroski JG. HIV-1 entry inhibitors in the side pocket. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">99</span>:243\xe2\x80\x93246. doi: 10.1016/S0092-8674(00)81655-4.</span> [<a href="/pubmed/10555140" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0092-8674(00)81655-4" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=HIV-1+entry+inhibitors+in+the+side+pocket&amp;author=JG+Sodroski&amp;volume=99&amp;publication_year=1999&amp;pages=243-246&amp;pmid=10555140&amp;doi=10.1016/S0092-8674(00)81655-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SRJ. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1996;<span class="ref-vol">93</span>:2186\xe2\x80\x932191. doi: 10.1073/pnas.93.5.2186.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC39932/">PMC free article</a>]</span> [<a href="/pubmed/8700906" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.93.5.2186" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Peptides+from+conserved+regions+of+paramyxovirus+fusion+(F)+proteins+are+potent+inhibitors+of+viral+fusion&amp;author=DM+Lambert&amp;author=S+Barney&amp;author=AL+Lambert&amp;author=K+Guthrie&amp;author=R+Medinas&amp;volume=93&amp;publication_year=1996&amp;pages=2186-2191&amp;pmid=8700906&amp;doi=10.1073/pnas.93.5.2186&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Young JK, Li D, Abramowitz MC, Morrison TG. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions. <span><span class="ref-journal">J Virol. </span>1999;<span class="ref-vol">73</span>:5945\xe2\x80\x935956.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC112656/">PMC free article</a>]</span> [<a href="/pubmed/10364347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Interaction+of+peptides+with+sequences+from+the+Newcastle+disease+virus+fusion+protein+heptad+repeat+regions&amp;author=JK+Young&amp;author=D+Li&amp;author=MC+Abramowitz&amp;author=TG+Morrison&amp;volume=73&amp;publication_year=1999&amp;pages=5945-5956&amp;pmid=10364347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Watanabe S, Takada A, Watanabe T, Ito H, Kida H, Kawaoka Y. Functional importance of the coiled-coil of the Ebola virus glycoprotein. <span><span class="ref-journal">J Virol. </span>2000;<span class="ref-vol">74</span>:10194\xe2\x80\x9310201. doi: 10.1128/JVI.74.21.10194-10201.2000.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC102058/">PMC free article</a>]</span> [<a href="/pubmed/11024148" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.74.21.10194-10201.2000" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Functional+importance+of+the+coiled-coil+of+the+Ebola+virus+glycoprotein&amp;author=S+Watanabe&amp;author=A+Takada&amp;author=T+Watanabe&amp;author=H+Ito&amp;author=H+Kida&amp;volume=74&amp;publication_year=2000&amp;pages=10194-10201&amp;pmid=11024148&amp;doi=10.1128/JVI.74.21.10194-10201.2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:8801\xe2\x80\x938811. doi: 10.1128/JVI.77.16.8801-8811.2003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC167208/">PMC free article</a>]</span> [<a href="/pubmed/12885899" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.77.16.8801-8811.2003" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=The+coronavirus+spike+protein+is+a+class+I+virus+fusion+protein:+structural+and+functional+characterization+of+the+fusion+core+complex&amp;author=BJ+Bosch&amp;author=R+van+der+Zee&amp;author=CA+de+Haan&amp;author=PJ+Rottier&amp;volume=77&amp;publication_year=2003&amp;pages=8801-8811&amp;pmid=12885899&amp;doi=10.1128/JVI.77.16.8801-8811.2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Bultmann H, Brandt CR. Peptides containing membrane-transiting motifs inhibit virus entry. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:36018\xe2\x80\x9336023. doi: 10.1074/jbc.M204849200.</span> [<a href="/pubmed/12130644" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.M204849200" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Peptides+containing+membrane-transiting+motifs+inhibit+virus+entry&amp;author=H+Bultmann&amp;author=CR+Brandt&amp;volume=277&amp;publication_year=2002&amp;pages=36018-36023&amp;pmid=12130644&amp;doi=10.1074/jbc.M204849200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Markosyan RM, Bates P, Cohen FS, Melikyan GB. A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. <span><span class="ref-journal">Biophys J. </span>2004;<span class="ref-vol">87</span>:3291\xe2\x80\x933298. doi: 10.1529/biophysj.104.047696.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1304797/">PMC free article</a>]</span> [<a href="/pubmed/15339808" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1529%2Fbiophysj.104.047696" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biophys+J&amp;title=A+study+of+low+pH-induced+refolding+of+Env+of+avian+sarcoma+and+leukosis+virus+into+a+six-helix+bundle&amp;author=RM+Markosyan&amp;author=P+Bates&amp;author=FS+Cohen&amp;author=GB+Melikyan&amp;volume=87&amp;publication_year=2004&amp;pages=3291-3298&amp;pmid=15339808&amp;doi=10.1529/biophysj.104.047696&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Rapaport D, Ovadia M, Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. <span><span class="ref-journal">Embo J. </span>1995;<span class="ref-vol">14</span>:5524\xe2\x80\x935531.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC394666/">PMC free article</a>]</span> [<a href="/pubmed/8521809" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Embo+J&amp;title=A+synthetic+peptide+corresponding+to+a+conserved+heptad+repeat+domain+is+a+potent+inhibitor+of+Sendai+virus-cell+fusion:+an+emerging+similarity+with+functional+domains+of+other+viruses&amp;author=D+Rapaport&amp;author=M+Ovadia&amp;author=Y+Shai&amp;volume=14&amp;publication_year=1995&amp;pages=5524-5531&amp;pmid=8521809&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Okazaki K, Kida H. A synthetic peptide from a heptad repeat region of herpesvirus glycoprotein B inhibits virus replication. <span><span class="ref-journal">J Gen Virol. </span>2004;<span class="ref-vol">85</span>:2131\xe2\x80\x932137. doi: 10.1099/vir.0.80051-0.</span> [<a href="/pubmed/15269351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1099%2Fvir.0.80051-0" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=A+synthetic+peptide+from+a+heptad+repeat+region+of+herpesvirus+glycoprotein+B+inhibits+virus+replication&amp;author=K+Okazaki&amp;author=H+Kida&amp;volume=85&amp;publication_year=2004&amp;pages=2131-2137&amp;pmid=15269351&amp;doi=10.1099/vir.0.80051-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Yao Q, Compans RW. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. <span><span class="ref-journal">Virology. </span>1996;<span class="ref-vol">223</span>:103\xe2\x80\x93112. doi: 10.1006/viro.1996.0459.</span> [<a href="/pubmed/8806544" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fviro.1996.0459" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Peptides+corresponding+to+the+heptad+repeat+sequence+of+human+parainfluenza+virus+fusion+protein+are+potent+inhibitors+of+virus+infection&amp;author=Q+Yao&amp;author=RW+Compans&amp;volume=223&amp;publication_year=1996&amp;pages=103-112&amp;pmid=8806544&amp;doi=10.1006/viro.1996.0459&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. <span><span class="ref-journal">Nature. </span>1995;<span class="ref-vol">375</span>:291\xe2\x80\x93298. doi: 10.1038/375291a0.</span> [<a href="/pubmed/7753193" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F375291a0" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The+envelope+glycoprotein+from+tick-borne+encephalitis+virus+at+2+A+resolution&amp;author=FA+Rey&amp;author=FX+Heinz&amp;author=C+Mandl&amp;author=C+Kunz&amp;author=SC+Harrison&amp;volume=375&amp;publication_year=1995&amp;pages=291-298&amp;pmid=7753193&amp;doi=10.1038/375291a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Lescar J, Roussel A, Wien MW, Navaza J, Fuller SD, Wengler G, Rey FA. The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. <span><span class="ref-journal">Cell. </span>2001;<span class="ref-vol">105</span>:137\xe2\x80\x93148. doi: 10.1016/S0092-8674(01)00303-8.</span> [<a href="/pubmed/11301009" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0092-8674(01)00303-8" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The+Fusion+glycoprotein+shell+of+Semliki+Forest+virus:+an+icosahedral+assembly+primed+for+fusogenic+activation+at+endosomal+pH&amp;author=J+Lescar&amp;author=A+Roussel&amp;author=MW+Wien&amp;author=J+Navaza&amp;author=SD+Fuller&amp;volume=105&amp;publication_year=2001&amp;pages=137-148&amp;pmid=11301009&amp;doi=10.1016/S0092-8674(01)00303-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. <span><span class="ref-journal">Cell. </span>2002;<span class="ref-vol">108</span>:717\xe2\x80\x93725. doi: 10.1016/S0092-8674(02)00660-8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4152842/">PMC free article</a>]</span> [<a href="/pubmed/11893341" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0092-8674(02)00660-8" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Structure+of+dengue+virus:+implications+for+flavivirus+organization,+maturation,+and+fusion&amp;author=RJ+Kuhn&amp;author=W+Zhang&amp;author=MG+Rossmann&amp;author=SV+Pletnev&amp;author=J+Corver&amp;volume=108&amp;publication_year=2002&amp;pages=717-725&amp;pmid=11893341&amp;doi=10.1016/S0092-8674(02)00660-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak D, Baker TS, Strauss JH, Kuhn RJ, Rossmann MG. Structures of immature flavivirus particles. <span><span class="ref-journal">Embo J. </span>2003;<span class="ref-vol">22</span>:2604\xe2\x80\x932613. doi: 10.1093/emboj/cdg270.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC156766/">PMC free article</a>]</span> [<a href="/pubmed/12773377" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Femboj%2Fcdg270" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Embo+J&amp;title=Structures+of+immature+flavivirus+particles&amp;author=Y+Zhang&amp;author=J+Corver&amp;author=PR+Chipman&amp;author=W+Zhang&amp;author=SV+Pletnev&amp;volume=22&amp;publication_year=2003&amp;pages=2604-2613&amp;pmid=12773377&amp;doi=10.1093/emboj/cdg270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. <span><span class="ref-journal">Embo J. </span>2004;<span class="ref-vol">23</span>:728\xe2\x80\x93738. doi: 10.1038/sj.emboj.7600064.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC380989/">PMC free article</a>]</span> [<a href="/pubmed/14963486" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fsj.emboj.7600064" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Embo+J&amp;title=Structure+of+a+flavivirus+envelope+glycoprotein+in+its+low-pH-induced+membrane+fusion+conformation&amp;author=S+Bressanelli&amp;author=K+Stiasny&amp;author=SL+Allison&amp;author=EA+Stura&amp;author=S+Duquerroy&amp;volume=23&amp;publication_year=2004&amp;pages=728-738&amp;pmid=14963486&amp;doi=10.1038/sj.emboj.7600064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusio. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">427</span>:313\xe2\x80\x93319. doi: 10.1038/nature02165.</span> [<a href="/pubmed/14737159" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnature02165" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure+of+the+dengue+virus+envelope+protein+after+membrane+fusio&amp;author=Y+Modis&amp;author=S+Ogata&amp;author=D+Clements&amp;author=SC+Harrison&amp;volume=427&amp;publication_year=2004&amp;pages=313-319&amp;pmid=14737159&amp;doi=10.1038/nature02165&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:6986\xe2\x80\x936991. doi: 10.1073/pnas.0832193100.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC165817/">PMC free article</a>]</span> [<a href="/pubmed/12759475" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0832193100" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A+ligand-binding+pocket+in+the+dengue+virus+envelope+glycoprotein&amp;author=Y+Modis&amp;author=S+Ogata&amp;author=D+Clements&amp;author=SC+Harrison&amp;volume=100&amp;publication_year=2003&amp;pages=6986-6991&amp;pmid=12759475&amp;doi=10.1073/pnas.0832193100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. Structure of West Nile virus. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">302</span>:248. doi: 10.1126/science.1089316.</span> [<a href="/pubmed/14551429" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1089316" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Structure+of+West+Nile+virus&amp;author=S+Mukhopadhyay&amp;author=BS+Kim&amp;author=PR+Chipman&amp;author=MG+Rossmann&amp;author=RJ+Kuhn&amp;volume=302&amp;publication_year=2003&amp;pages=248&amp;pmid=14551429&amp;doi=10.1126/science.1089316&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. <span><span class="ref-journal">Nat Rev Microbiol. </span>2005;<span class="ref-vol">3</span>:13\xe2\x80\x9322. doi: 10.1038/nrmicro1067.</span> [<a href="/pubmed/15608696" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnrmicro1067" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&amp;title=A+structural+perspective+of+the+flavivirus+life+cycle&amp;author=S+Mukhopadhyay&amp;author=RJ+Kuhn&amp;author=MG+Rossmann&amp;volume=3&amp;publication_year=2005&amp;pages=13-22&amp;pmid=15608696&amp;doi=10.1038/nrmicro1067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Rey FA. Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:6899\xe2\x80\x936901. doi: 10.1073/pnas.1332695100.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC165800/">PMC free article</a>]</span> [<a href="/pubmed/12782795" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.1332695100" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Dengue+virus+envelope+glycoprotein+structure:+new+insight+into+its+interactions+during+viral+entry&amp;author=FA+Rey&amp;volume=100&amp;publication_year=2003&amp;pages=6899-6901&amp;pmid=12782795&amp;doi=10.1073/pnas.1332695100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">WHO  . <span class="ref-journal">Dengue and dengue haemorrhagic fever.</span> http: //www.who.int/mediacentre/factsheets/fs117/en/,; 2002.  [<a href="/pubmed/12238319" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Dengue+and+dengue+haemorrhagic+fever&amp;publication_year=2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Hotta H, Sanchez LF, Takada H, Homma M, Kotani S. Enhancement of dengue virus infection in cultured mouse macrophages by lipophilic derivatives of muramyl peptides. <span><span class="ref-journal">Microbiol Immunol. </span>1985;<span class="ref-vol">29</span>:533\xe2\x80\x93541. doi: 10.1111/j.1348-0421.1985.tb00855.x.</span> [<a href="/pubmed/4046890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1348-0421.1985.tb00855.x" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbiol+Immunol&amp;title=Enhancement+of+dengue+virus+infection+in+cultured+mouse+macrophages+by+lipophilic+derivatives+of+muramyl+peptides&amp;author=H+Hotta&amp;author=LF+Sanchez&amp;author=H+Takada&amp;author=M+Homma&amp;author=S+Kotani&amp;volume=29&amp;publication_year=1985&amp;pages=533-541&amp;pmid=4046890&amp;doi=10.1111/j.1348-0421.1985.tb00855.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Halstead SB. Pathogenesis of dengue: challenges to molecular biology. <span><span class="ref-journal">Science. </span>1988;<span class="ref-vol">239</span>:476\xe2\x80\x93481. doi: 10.1126/science.3277268.</span> [<a href="/pubmed/3277268" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.3277268" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Pathogenesis+of+dengue:+challenges+to+molecular+biology&amp;author=SB+Halstead&amp;volume=239&amp;publication_year=1988&amp;pages=476-481&amp;pmid=3277268&amp;doi=10.1126/science.3277268&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Guy B, Chanthavanich P, Gimenez S, Sirivichayakul C, Sabchareon A, Begue S, Yoksan S, Luxemburger C, Lang J. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine. <span><span class="ref-journal">Vaccine. </span>2004;<span class="ref-vol">22</span>:3563\xe2\x80\x933574. doi: 10.1016/j.vaccine.2004.03.042.</span> [<a href="/pubmed/15315835" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.vaccine.2004.03.042" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Evaluation+by+flow+cytometry+of+antibody-dependent+enhancement+(ADE)+of+dengue+infection+by+sera+from+Thai+children+immunized+with+a+live-attenuated+tetravalent+dengue+vaccine&amp;author=B+Guy&amp;author=P+Chanthavanich&amp;author=S+Gimenez&amp;author=C+Sirivichayakul&amp;author=A+Sabchareon&amp;volume=22&amp;publication_year=2004&amp;pages=3563-3574&amp;pmid=15315835&amp;doi=10.1016/j.vaccine.2004.03.042&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chokejindachai W, Jagsudee A, Saluzzo JF, Bhamarapravati N. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2002;<span class="ref-vol">66</span>:264\xe2\x80\x93272.</span> [<a href="/pubmed/12139219" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=Safety+and+immunogenicity+of+tetravalent+live-attenuated+dengue+vaccines+in+Thai+adult+volunteers:+role+of+serotype+concentration,+ratio,+and+multiple+doses&amp;author=A+Sabchareon&amp;author=J+Lang&amp;author=P+Chanthavanich&amp;author=S+Yoksan&amp;author=R+Forrat&amp;volume=66&amp;publication_year=2002&amp;pages=264-272&amp;pmid=12139219&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Edelman R, Wasserman SS, Bodison SA, Putnak RJ, Eckels KH, Tang D, Kanesa-Thasan N, Vaughn DW, Innis BL, Sun W. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2003;<span class="ref-vol">69</span>:48\xe2\x80\x9360.</span> [<a href="/pubmed/14740955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=Phase+I+trial+of+16+formulations+of+a+tetravalent+live-attenuated+dengue+vaccine&amp;author=R+Edelman&amp;author=SS+Wasserman&amp;author=SA+Bodison&amp;author=RJ+Putnak&amp;author=KH+Eckels&amp;volume=69&amp;publication_year=2003&amp;pages=48-60&amp;pmid=14740955&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Kanesa-Thasan N, Sun W, Ludwig GV, Rossi C, Putnak JR, Mangiafico JA, Innis BL, Edelman R. Atypical antibody responses in dengue vaccine recipients. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2003;<span class="ref-vol">69</span>:32\xe2\x80\x9338.</span> [<a href="/pubmed/14740953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=Atypical+antibody+responses+in+dengue+vaccine+recipients&amp;author=N+Kanesa-Thasan&amp;author=W+Sun&amp;author=GV+Ludwig&amp;author=C+Rossi&amp;author=JR+Putnak&amp;volume=69&amp;publication_year=2003&amp;pages=32-38&amp;pmid=14740953&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Kanesa-thasan N, Sun W, Kim-Ahn G, Van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CHJ. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. <span><span class="ref-journal">Vaccine. </span>2001;<span class="ref-vol">19</span>:3179\xe2\x80\x933188. doi: 10.1016/S0264-410X(01)00020-2.</span> [<a href="/pubmed/11312014" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0264-410X(01)00020-2" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Safety+and+immunogenicity+of+attenuated+dengue+virus+vaccines+(Aventis+Pasteur)+in+human+volunteers&amp;author=N+Kanesa-thasan&amp;author=W+Sun&amp;author=G+Kim-Ahn&amp;author=S+Van+Albert&amp;author=JR+Putnak&amp;volume=19&amp;publication_year=2001&amp;pages=3179-3188&amp;pmid=11312014&amp;doi=10.1016/S0264-410X(01)00020-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Bhamarapravati N, Sutee Y. Live attenuated tetravalent dengue vaccine. <span><span class="ref-journal">Vaccine. </span>2000;<span class="ref-vol">18 Suppl 2</span>:44\xe2\x80\x9347. doi: 10.1016/S0264-410X(00)00040-2.</span> [<a href="/pubmed/10821973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0264-410X(00)00040-2" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Live+attenuated+tetravalent+dengue+vaccine&amp;author=N+Bhamarapravati&amp;author=Y+Sutee&amp;volume=18+Suppl+2&amp;publication_year=2000&amp;pages=44-47&amp;pmid=10821973&amp;doi=10.1016/S0264-410X(00)00040-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Barrett AD. Current status of flavivirus vaccines. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2001;<span class="ref-vol">951</span>:262\xe2\x80\x93271. doi: 10.1111/j.1749-6632.2001.tb02702.x.</span> [<a href="/pubmed/11797783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1749-6632.2001.tb02702.x" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+N+Y+Acad+Sci&amp;title=Current+status+of+flavivirus+vaccines&amp;author=AD+Barrett&amp;volume=951&amp;publication_year=2001&amp;pages=262-271&amp;pmid=11797783&amp;doi=10.1111/j.1749-6632.2001.tb02702.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Sun W, Edelman R, Kanesa-Thasan N, Eckels KH, Putnak JR, King AD, Houng HS, Tang D, Scherer JM, Hoke CHJ, Innis BL. Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2003;<span class="ref-vol">69</span>:24\xe2\x80\x9331.</span> [<a href="/pubmed/14740952" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=Vaccination+of+human+volunteers+with+monovalent+and+tetravalent+live-attenuated+dengue+vaccine+candidates&amp;author=W+Sun&amp;author=R+Edelman&amp;author=N+Kanesa-Thasan&amp;author=KH+Eckels&amp;author=JR+Putnak&amp;volume=69&amp;publication_year=2003&amp;pages=24-31&amp;pmid=14740952&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, Lang J, Ocran S, Mitchell F, Parsons M, Brown N, Brandler S, Fournier C, Barrere B, Rizvi F, Travassos A, Nichols R, Trent D, Monath T. Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:4761\xe2\x80\x934775. doi: 10.1128/JVI.78.9.4761-4775.2004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC387722/">PMC free article</a>]</span> [<a href="/pubmed/15078958" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.78.9.4761-4775.2004" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Safety+and+efficacy+of+chimeric+yellow+Fever-dengue+virus+tetravalent+vaccine+formulations+in+nonhuman+primates&amp;author=F+Guirakhoo&amp;author=K+Pugachev&amp;author=Z+Zhang&amp;author=G+Myers&amp;author=I+Levenbook&amp;volume=78&amp;publication_year=2004&amp;pages=4761-4775&amp;pmid=15078958&amp;doi=10.1128/JVI.78.9.4761-4775.2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Guirakhoo F, Pugachev K, Arroyo J, Miller C, Zhang ZX, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Draper K, Monath TP. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. <span><span class="ref-journal">Virology. </span>2002;<span class="ref-vol">298</span>:146\xe2\x80\x93159. doi: 10.1006/viro.2002.1462.</span> [<a href="/pubmed/12093182" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fviro.2002.1462" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Viremia+and+immunogenicity+in+nonhuman+primates+of+a+tetravalent+yellow+fever-dengue+chimeric+vaccine:+genetic+reconstructions,+dose+adjustment,+and+antibody+responses+against+wild-type+dengue+virus+isolates&amp;author=F+Guirakhoo&amp;author=K+Pugachev&amp;author=J+Arroyo&amp;author=C+Miller&amp;author=ZX+Zhang&amp;volume=298&amp;publication_year=2002&amp;pages=146-159&amp;pmid=12093182&amp;doi=10.1006/viro.2002.1462&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Wimley WC, White SH. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. <span><span class="ref-journal">Nat Struct Biol. </span>1996;<span class="ref-vol">3</span>:842\xe2\x80\x93848. doi: 10.1038/nsb1096-842.</span> [<a href="/pubmed/8836100" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnsb1096-842" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Struct+Biol&amp;title=Experimentally+determined+hydrophobicity+scale+for+proteins+at+membrane+interfaces&amp;author=WC+Wimley&amp;author=SH+White&amp;volume=3&amp;publication_year=1996&amp;pages=842-848&amp;pmid=8836100&amp;doi=10.1038/nsb1096-842&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Giannecchini S, Bonci F, Pistello M, Matteucci D, Sichi O, Rovero P, Bendinelli M. The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry. <span><span class="ref-journal">Virology. </span>2004;<span class="ref-vol">320</span>:156\xe2\x80\x93166. doi: 10.1016/j.virol.2003.12.001.</span> [<a href="/pubmed/15003871" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virol.2003.12.001" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=The+membrane-proximal+tryptophan-rich+region+in+the+transmembrane+glycoprotein+ectodomain+of+feline+immunodeficiency+virus+is+important+for+cell+entry&amp;author=S+Giannecchini&amp;author=F+Bonci&amp;author=M+Pistello&amp;author=D+Matteucci&amp;author=O+Sichi&amp;volume=320&amp;publication_year=2004&amp;pages=156-166&amp;pmid=15003871&amp;doi=10.1016/j.virol.2003.12.001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Garry RF, Dash S. Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. <span><span class="ref-journal">Virology. </span>2003;<span class="ref-vol">307</span>:255\xe2\x80\x93265. doi: 10.1016/S0042-6822(02)00065-X.</span> [<a href="/pubmed/12667795" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0042-6822(02)00065-X" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Proteomics+computational+analyses+suggest+that+hepatitis+C+virus+E1+and+pestivirus+E2+envelope+glycoproteins+are+truncated+class+II+fusion+proteins&amp;author=RF+Garry&amp;author=S+Dash&amp;volume=307&amp;publication_year=2003&amp;pages=255-265&amp;pmid=12667795&amp;doi=10.1016/S0042-6822(02)00065-X&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Garry CE, Garry RF. Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes) <span><span class="ref-journal">Theor Biol Med Model. </span>2004;<span class="ref-vol">1</span>:10. doi: 10.1186/1742-4682-1-10.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC535339/">PMC free article</a>]</span> [<a href="/pubmed/15544707" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1742-4682-1-10" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theor+Biol+Med+Model&amp;title=Proteomics+computational+analyses+suggest+that+the+carboxyl+terminal+glycoproteins+of+Bunyaviruses+are+class+II+viral+fusion+protein+(beta-penetrenes)&amp;author=CE+Garry&amp;author=RF+Garry&amp;volume=1&amp;publication_year=2004&amp;pages=10&amp;pmid=15544707&amp;doi=10.1186/1742-4682-1-10&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Gibbons DL, Vaney MC, Roussel A, Vigouroux A, Reilly B, Lepault J, Kielian M, Rey FA. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">427</span>:320\xe2\x80\x93325. doi: 10.1038/nature02239.</span> [<a href="/pubmed/14737160" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnature02239" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Conformational+change+and+protein-protein+interactions+of+the+fusion+protein+of+Semliki+Forest+virus&amp;author=DL+Gibbons&amp;author=MC+Vaney&amp;author=A+Roussel&amp;author=A+Vigouroux&amp;author=B+Reilly&amp;volume=427&amp;publication_year=2004&amp;pages=320-325&amp;pmid=14737160&amp;doi=10.1038/nature02239&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Beasley DW, Barrett AD. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:13097\xe2\x80\x9313100. doi: 10.1128/JVI.76.24.13097-13100.2002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC136710/">PMC free article</a>]</span> [<a href="/pubmed/12438639" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.76.24.13097-13100.2002" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Identification+of+neutralizing+epitopes+within+structural+domain+III+of+the+West+Nile+virus+envelope+protein&amp;author=DW+Beasley&amp;author=AD+Barrett&amp;volume=76&amp;publication_year=2002&amp;pages=13097-13100&amp;pmid=12438639&amp;doi=10.1128/JVI.76.24.13097-13100.2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Volk DE, Beasley DW, Kallick DA, Holbrook MR, Barrett AD, Gorenstein DG. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:38755\xe2\x80\x9338761. doi: 10.1074/jbc.M402385200.</span> [<a href="/pubmed/15190071" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.M402385200" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Solution+structure+and+antibody+binding+studies+of+the+envelope+protein+domain+III+from+the+New+York+strain+of+West+Nile+virus&amp;author=DE+Volk&amp;author=DW+Beasley&amp;author=DA+Kallick&amp;author=MR+Holbrook&amp;author=AD+Barrett&amp;volume=279&amp;publication_year=2004&amp;pages=38755-38761&amp;pmid=15190071&amp;doi=10.1074/jbc.M402385200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Chen Y, Maguire T, Marks RM. Demonstration of binding of dengue virus envelope protein to target cells. <span><span class="ref-journal">J Virol. </span>1996;<span class="ref-vol">70</span>:8765\xe2\x80\x938772.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC190973/">PMC free article</a>]</span> [<a href="/pubmed/8971005" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Demonstration+of+binding+of+dengue+virus+envelope+protein+to+target+cells&amp;author=Y+Chen&amp;author=T+Maguire&amp;author=RM+Marks&amp;volume=70&amp;publication_year=1996&amp;pages=8765-8772&amp;pmid=8971005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:4002\xe2\x80\x934007. doi: 10.1128/JVI.75.8.4002-4007.2001.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114894/">PMC free article</a>]</span> [<a href="/pubmed/11264392" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.75.8.4002-4007.2001" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Biophysical+characterization+and+vector-specific+antagonist+activity+of+domain+III+of+the+tick-borne+flavivirus+envelope+protein&amp;author=S+Bhardwaj&amp;author=M+Holbrook&amp;author=RE+Shope&amp;author=AD+Barrett&amp;author=SJ+Watowich&amp;volume=75&amp;publication_year=2001&amp;pages=4002-4007&amp;pmid=11264392&amp;doi=10.1128/JVI.75.8.4002-4007.2001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Wu KP, Wu CW, Tsao YP, Kuo TW, Lou YC, Lin CW, Wu SC, Cheng JW.  <span class="ref-journal">J Biol Chem.</span> 2003. Structural basis of a Flavivirus recognized by its neutralizing antibody: Solution structure of the domain III of the Japanese Encephalitis virus envelope protein. [<a href="/pubmed/12952958" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=J+Biol+Chem&amp;author=KP+Wu&amp;author=CW+Wu&amp;author=YP+Tsao&amp;author=TW+Kuo&amp;author=YC+Lou&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Hung SL, Lee PL, Chen HW, Chen LK, Kao CL, King CC. Analysis of the steps involved in Dengue virus entry into host cells. <span><span class="ref-journal">Virology. </span>1999;<span class="ref-vol">257</span>:156\xe2\x80\x93167. doi: 10.1006/viro.1999.9633.</span> [<a href="/pubmed/10208929" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fviro.1999.9633" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Analysis+of+the+steps+involved+in+Dengue+virus+entry+into+host+cells&amp;author=SL+Hung&amp;author=PL+Lee&amp;author=HW+Chen&amp;author=LK+Chen&amp;author=CL+Kao&amp;volume=257&amp;publication_year=1999&amp;pages=156-167&amp;pmid=10208929&amp;doi=10.1006/viro.1999.9633&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. <span><span class="ref-journal">J Virol. </span>1999;<span class="ref-vol">73</span>:5605\xe2\x80\x935612.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC112618/">PMC free article</a>]</span> [<a href="/pubmed/10364309" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Mapping+of+functional+elements+in+the+stem-anchor+region+of+tick-borne+encephalitis+virus+envelope+protein+E&amp;author=SL+Allison&amp;author=K+Stiasny&amp;author=K+Stadler&amp;author=CW+Mandl&amp;author=FX+Heinz&amp;volume=73&amp;publication_year=1999&amp;pages=5605-5612&amp;pmid=10364309&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. <span><span class="ref-journal">Lancet. </span>2004;<span class="ref-vol">363</span>:938\xe2\x80\x93947. doi: 10.1016/S0140-6736(04)15788-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7140173/">PMC free article</a>]</span> [<a href="/pubmed/15043961" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(04)15788-7" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Interaction+between+heptad+repeat+1+and+2+regions+in+spike+protein+of+SARS-associated+coronavirus:+implications+for+virus+fusogenic+mechanism+and+identification+of+fusion+inhibitors&amp;author=S+Liu&amp;author=G+Xiao&amp;author=Y+Chen&amp;author=Y+He&amp;author=J+Niu&amp;volume=363&amp;publication_year=2004&amp;pages=938-947&amp;pmid=15043961&amp;doi=10.1016/S0140-6736(04)15788-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Sia SK, Carr PA, Cochran AG, Malashkevich VN, Kim PS. Short constrained peptides that inhibit HIV-1 entry. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2002;<span class="ref-vol">99</span>:14664\xe2\x80\x9314669. doi: 10.1073/pnas.232566599.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC137476/">PMC free article</a>]</span> [<a href="/pubmed/12417739" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.232566599" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Short+constrained+peptides+that+inhibit+HIV-1+entry&amp;author=SK+Sia&amp;author=PA+Carr&amp;author=AG+Cochran&amp;author=VN+Malashkevich&amp;author=PS+Kim&amp;volume=99&amp;publication_year=2002&amp;pages=14664-14669&amp;pmid=12417739&amp;doi=10.1073/pnas.232566599&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. <span><span class="ref-journal">Nat Med. </span>2005;<span class="ref-vol">11</span>:522\xe2\x80\x9330. doi: 10.1038/nm1240.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1458527/">PMC free article</a>]</span> [<a href="/pubmed/15852016" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnm1240" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Development+of+a+humanized+monoclonal+antibody+with+therapeutic+potential+against+West+Nile+virus&amp;author=T+Oliphant&amp;author=M+Engle&amp;author=GE+Nybakken&amp;author=C+Doane&amp;author=S+Johnson&amp;volume=11&amp;publication_year=2005&amp;pages=522-30&amp;pmid=15852016&amp;doi=10.1038/nm1240&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Qureshi NM, Coy DH, Garry RF, LA H. Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. <span><span class="ref-journal">AIDS. </span>1990;<span class="ref-vol">4</span>:553\xe2\x80\x93558. doi: 10.1097/00002030-199006000-00009.</span> [<a href="/pubmed/1974767" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00002030-199006000-00009" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=Characterization+of+a+putative+cellular+receptor+for+HIV-1+transmembrane+glycoprotein+using+synthetic+peptides&amp;author=NM+Qureshi&amp;author=DH+Coy&amp;author=RF+Garry&amp;author=H+LA&amp;volume=4&amp;publication_year=1990&amp;pages=553-558&amp;pmid=1974767&amp;doi=10.1097/00002030-199006000-00009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1177995&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1177995/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1177995/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1177995/pdf/12985_2005_Article_64.pdf">PDF (4.3M)</a></li> | <li><a href="#" data-citationid="PMC1177995" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1177995%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1177995%2F&amp;text=Peptide%20inhibitors%20of%20dengue%20virus%20and%20West%20Nile%20virus%20infectivity"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1177995%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="15927084" data-aiid="7095642" data-aid="1177995" data-iid="354810" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1177995" data-md5="6b42ecfacf54c53b8d66a56125b05e86"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:08:23-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B663BE999B4710000000007490749&amp;ncbi_session=8A1B663BE99AA461_1865SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1177995%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1177995/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B663BE99AA461_1865SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'